COMPLETE BLOOD COUNT (CBC)*
W.B.C. INDICES
Method: Impedance,Flowcytometry,Microscopy,Calculated
Total W.B.C. Count.
Method: Method:Impedance
10500
/cu.mm
4500 - 11000
Neutrophils
Method: Method:VCS Technology/Microscopy
73
%
50 - 70
Lymphocytes
Method: Method:VCS Technology/Microscopy
23
%
20 - 40
Eosinophils
Method: Method:VCS Technology/Microscopy
02
%
02 - 06
Monocytes
Method: Method:VCS Technology/Microscopy
02
%
02 - 12
Basophils
Method: Method:VCS Technology/Microscopy
00
%
00 - 01
Absolute Neutrophils Count
Method: Method:Calculated
7665.00
/cumm
1600 - 7260
Absolute Lymphocytes Count
Method: Method:Calculated
2415.00
/cumm
960 - 4400
Absolute Monocyte Count
Method: Method:Calculated
3
%
-
Absolute Eosinophils Count
Method: Method:Calculated
210.00
/cumm
45 - 440
 
R.B.C. INDICES
Method: Photometric Measurement,Impedance,Calculated
Hemoglobin(Hb)
Method: Method: Photometric Measurement
16
g/dl
12.0.-15.50
R.B.C. COUNT.
Method: Method:Electrical impedence
5.33
10^6/uL
4.5 - 6.5
Hematocrit(PCV)
Method: Method:impedance
51.20
%
32 - 47
MCV
Method: Method:Calculated
96.06
fl
82 - 98
MCH
Method: Method:Calculated
30.02
pg
27 - 33
MCHC
Method: Method:Calculated
31.25
g/dl
32 - 36
Red Cell Distribution Width (RDW-CV)
Method: Method:Electrical Impedance
14.6
%
11.0-14.5
 
PLATELETS INDICES
Method: Impedance,Microscopy,Calculated
Platelets Count
Method: Method:Electrical Impedence
150
thou/cu.mm
150 - 450
Mean Platelet Volume (MPV)
10
fl
7.0 - 11.0
P.D.W.
25
fl
8.1 - 24.9
WIDAL SLIDE TEST
Widal Result
POSITIVE
NEGATIVE
S. Typhi "0" Antigen
Method: Direct Agglutination Reaction
1:160
<1:80
S. Typhi "H" Antigen
Method: Direct Agglutination Reaction
1:80
<1:80
S. Paratyphi 0(H) Antigen
Method: Direct Agglutination Reaction
1:40
<1:80
S. Paratyphi A(H) Antigen
Method: Direct Agglutination Reaction
1:40
<1:80
Widal Comments

INTERPRETATION OF RESULT

• Agglutination is a positive test result. The titre of the patient serum corresponds to the visible agglutination in the test Circle with the smallest amount of serum sample.
• Agglutinin titre greater than 1:80 is considered as significant infection and low titres indicate absence of infection

REMARK

1.Positive results obtained in the slide test should be confirmed with the tube test to establish whether the titres are diagnostically significant or not.
2.TAB vaccinated patients may show a high titre of antibodies to each of the antigens. Similarly, an amnestic response to other vaccines and unrelated fevers in case of patients who have had prior infection or immunization may give a false result.
3.Agglutinins usually appear by the end of the first week of infection, blood sample taken earlier may give a negative result.
4.Arising titre is more significant than a single high titre. It is therefore necessary to evaluate two or more serum samples taken at 4- 6 days intervals after the onset of the disease.
5.'O' being a somatic antigen brings about a coarse, compact,granular agglutination Whereas 'H' being a flagellar antigen brings about larger, loose, flocculant agglutination.
.

LIVER FUNCTION TEST (LFT)
Total Bilirubin
Method: Spectrophotometry-Diazo
1.4
mg/dl
0.2 - 1.2
Direct Bilirubin
Method: Spectrophotometry-Diazo
0.86
mg/dl
00 - 0.40
Indirect Bilirubin
Method: Calculated
0.54
mg/dl
00 - 0.85
SGOT (AST)
Method: Spectrophotometry-IFCC Without Pyridoxal PO4
9
U/L
00 - 46
SGPT (ALT)
Method: Spectrophotometry-IFCC Without Pyridoxal PO4
7
U/L
09 - 49
Alkaline Phosphatase
Method: IFCC
5.6
U/L
43 - 128
Total Protein
Method: Biuret Method
56.7
g/dl
06 - 8.5
Albumin
Method: Spectrophotometry-Biuret
4.6
g/dl
3.2 - 5.5
Globulin
Method: Calculated
52.10
g/dl
2.3 - 3.6
Albumin/Globulin Ratio
Method: Calculated
0.09
1.1 - 2.1
Comment
Liver Function Test (LFT) is a panel of biochemical tests used to assess liver function and detect liver injury. It includes measurement of bilirubin, AST (SGOT), ALT (SGPT), alkaline phosphatase (ALP), total protein, albumin, and globulin. Abnormal values may indicate hepatocellular damage, cholestatic disease, alcohol-related liver disease, viral hepatitis, or other hepatic disorders. Results should be interpreted in conjunction with clinical findings and other investigations.
SGPT (ALT)
SGPT (ALT)
Method: Spectrophotometry-IFCC Without Pyridoxal PO4
51
U/L
09 - 49
Comment

Clinical Significance :

Elevated alanine aminotransferase (ALT) values are seen in parenchymal liver diseases characterized by a destruction of hepatocytes. Values are at least 10 times higher the normal range and may reach up to 100 times the upper reference limit. Commonly, values are seen to be 20 - 50 times higher than normal. In infectious hepatitis and other inflammatory conditions affecting the liver.

SGOT(AST)
SGOT (AST)
Method: Spectrophotometry-IFCC Without Pyridoxal PO4
47
U/L
00 - 46
Comment


Clinical Significance :

Serum glutamic oxaloacetic transaminase(SGOT), an enzyme that is normally present in liver and heart cells. SGOT is released into blood when the liver or heart is damaged. The blood SGOT levels are thus elevated with liver damage (for example, from viral hepatitis) or with an insult to the heart (for example, from a heart attack). Some medications can also raise SGOT levels. .